DBVT
Price
$15.73
Change
-$0.28 (-1.75%)
Updated
Jul 2, 04:59 PM (EDT)
Capitalization
975.3M
Intraday BUY SELL Signals
PCSA
Price
$2.13
Change
+$0.27 (+14.52%)
Updated
Jul 2, 04:57 PM (EDT)
Capitalization
5.98M
Intraday BUY SELL Signals
Interact to see
Advertisement

DBVT vs PCSA

DBVT vs PCSA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
DBVT vs. PCSA commentary
Jul 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBVT is a Hold and PCSA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2026
Stock price -- (DBVT: $16.01 vs. PCSA: $1.86)
Brand notoriety: DBVT and PCSA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DBVT: 81% vs. PCSA: 41%
Market capitalization -- DBVT: $975.3M vs. PCSA: $5.98M
DBVT [@Biotechnology] is valued at $975.3M. PCSA’s [@Biotechnology] market capitalization is $5.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $134.02B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DBVT’s FA Score shows that 0 FA rating(s) are green whilePCSA’s FA Score has 1 green FA rating(s).

  • DBVT’s FA Score: 0 green, 5 red.
  • PCSA’s FA Score: 1 green, 4 red.
According to our system of comparison, DBVT is a better buy in the long-term than PCSA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DBVT’s TA Score shows that 5 TA indicator(s) are bullish while PCSA’s TA Score has 2 bullish TA indicator(s).

  • DBVT’s TA Score: 5 bullish, 3 bearish.
  • PCSA’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, DBVT is a better buy in the short-term than PCSA.

Price Growth

DBVT (@Biotechnology) experienced а -0.06% price change this week, while PCSA (@Biotechnology) price change was -1.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.30%. For the same industry, the average monthly price growth was +5.93%, and the average quarterly price growth was +1921.84%.

Industries' Descriptions

@Biotechnology (+2.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DBVT($975M) has a higher market cap than PCSA($5.98M). DBVT YTD gains are higher at: -16.484 vs. PCSA (-35.417). PCSA has higher annual earnings (EBITDA): -14.47M vs. DBVT (-160.22M). DBVT has more cash in the bank: 229M vs. PCSA (1.69M). PCSA has less debt than DBVT: PCSA (0) vs DBVT (6.1M). DBVT (0) and PCSA (0) have equivalent revenues.
DBVTPCSADBVT / PCSA
Capitalization975M5.98M16,307%
EBITDA-160.22M-14.47M1,107%
Gain YTD-16.484-35.41747%
P/E RatioN/AN/A-
Revenue00-
Total Cash229M1.69M13,542%
Total Debt6.1M0-
FUNDAMENTALS RATINGS
DBVT: Fundamental Ratings
DBVT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DBVTPCSA
RSI
ODDS (%)
Bullish Trend 4 days ago
69%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
82%
Momentum
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 13 days ago
80%
N/A
Declines
ODDS (%)
Bearish Trend 18 days ago
90%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
81%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
DBVT
Daily Signal:
Gain/Loss:
PCSA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GIEYX17.150.18
+1.06%
GuideStone Funds International Eq Instl
RMFAX63.690.40
+0.63%
American Funds American Mutual R-1
ACGMX24.600.06
+0.24%
Invesco Growth and Income Y
MECEX15.35-0.06
-0.39%
NYLI Epoch Capital Growth Class C
MAGKX18.06-0.21
-1.15%
MoA Small Cap Growth Fund

DBVT and

Correlation & Price change

A.I.dvisor tells us that DBVT and CRDF have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DBVT and CRDF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DBVT
1D Price
Change %
DBVT100%
N/A
CRDF - DBVT
32%
Poorly correlated
N/A
CGEN - DBVT
30%
Poorly correlated
N/A
TAOX - DBVT
29%
Poorly correlated
N/A
PCSA - DBVT
29%
Poorly correlated
N/A
GLSI - DBVT
29%
Poorly correlated
N/A
More

PCSA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCSA has been loosely correlated with INO. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PCSA jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCSA
1D Price
Change %
PCSA100%
N/A
INO - PCSA
38%
Loosely correlated
N/A
ONCO - PCSA
35%
Loosely correlated
N/A
IBO - PCSA
32%
Poorly correlated
-2.48%
RXRX - PCSA
31%
Poorly correlated
N/A
DBVT - PCSA
28%
Poorly correlated
N/A
More